Traducción en proceso. Mostrando versión en inglés.

Danaher nears $10 bln deal to buy med tech firm Masimo- FT

ArchivadoVerificado|5 artículos|4 fuentes|1 bloques

Detectado: Actualizado: Analizado:

Finanzas

Hechos Reportados

Datos observables compartidos por todas las narrativas

•Danaher Corporation is reported to be nearing an agreement to acquire Masimo Corporation, a medical technology firm.
•The potential transaction value for Danaher’s acquisition of Masimo is described as nearly $10 billion in multiple reports.
•The Financial Times is cited as the primary source reporting that Danaher is closing in on this Masimo deal.
•Masimo operates in the medical technology sector, including patient monitoring and related devices.
•The reported Masimo deal would be another significant M&A transaction for Danaher, which has an established history of acquisitions.

Qué Podría Pasar Si...

▸If Danaher and Masimo finalize and announce a definitive $10 billion acquisition agreement Danaher’s medical technology portfolio and revenue exposure to patient monitoring and hospital equipment markets could increase, potentially altering competitive dynamics with other large med-tech players.

Inicia sesión para ver todos los escenarios y señales.

Exposición de Mercado

AccionesDanaher Corporation (DHR)Mayor Volatilidad

If investors reassess Danaher’s leverage, integration risk, and growth prospects in light of a nearly $10 billion Masimo acquisition, DHR shares could experience heightened price swings.

Actores Clave

Organizaciones

🏛Danaher Corporation 🏛Masimo

Cobertura por Fuentes

FINANCE

5 artículos

Más cobertura relacionada

Más sobre Danaher Corporation
Más sobre Masimo

Señales

Single-block coverage

Eventos Relacionados

▸Agilent acquires Biocare Medical for $950M to expand pathology portfolioArchivado ▸Medtronic to acquire Scientia Vascular for $550MArchivado ▸Merck Nears $6 Billion Acquisition of Terns Pharma for Cancer DrugsArchivado ▸Generate Biomedicines Files for $425 Million Nasdaq IPOArchivado ▸Emergent BioSolutions sets $720M–$760M revenue target for 2026

Fuentes (5)

FINANCECNBC - Top NewsDanaher is tapping the M&A well yet again. But we might have had enough FINANCESeeking Alpha - Market NewsDanaher nears $10B acquisition of medical tech company Masimo, FT reports FINANCEInvesting.com - NewsDanaher closes in on nearly $10 billion deal for Masimo, FT reports FINANCEInvesting.com - News

Danaher Corporation is reportedly close to acquiring medical technology company Masimo in a transaction valued at nearly $10 billion, according to multiple reports citing the Financial Times. The deal would mark a major expansion of Danaher’s presence in patient monitoring and medical devices, and underscores continued large-scale M&A activity in the healthcare technology sector. Investors and competitors will be watching valuation, integration risks, and potential strategic shifts in Masimo’s product portfolio and partnerships.